CO6430490A2 - Biomarcadores de proteina para el diagnostico de enfermedades de tejido blando y como objetivos terapeuticos para intervenciones de cuidado oral - Google Patents

Biomarcadores de proteina para el diagnostico de enfermedades de tejido blando y como objetivos terapeuticos para intervenciones de cuidado oral

Info

Publication number
CO6430490A2
CO6430490A2 CO11126599A CO11126599A CO6430490A2 CO 6430490 A2 CO6430490 A2 CO 6430490A2 CO 11126599 A CO11126599 A CO 11126599A CO 11126599 A CO11126599 A CO 11126599A CO 6430490 A2 CO6430490 A2 CO 6430490A2
Authority
CO
Colombia
Prior art keywords
biomarkers
expression
diagnosis
oral cavity
soft tissue
Prior art date
Application number
CO11126599A
Other languages
English (en)
Spanish (es)
Inventor
Harsh M Trivedi
Tao Xu
Ying Yang
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Publication of CO6430490A2 publication Critical patent/CO6430490A2/es

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • G01N33/56955Bacteria involved in periodontal diseases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/948Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486Metalloendopeptidases (3.4.24)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/60Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CO11126599A 2009-04-01 2011-09-27 Biomarcadores de proteina para el diagnostico de enfermedades de tejido blando y como objetivos terapeuticos para intervenciones de cuidado oral CO6430490A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16567409P 2009-04-01 2009-04-01

Publications (1)

Publication Number Publication Date
CO6430490A2 true CO6430490A2 (es) 2012-04-30

Family

ID=42813186

Family Applications (1)

Application Number Title Priority Date Filing Date
CO11126599A CO6430490A2 (es) 2009-04-01 2011-09-27 Biomarcadores de proteina para el diagnostico de enfermedades de tejido blando y como objetivos terapeuticos para intervenciones de cuidado oral

Country Status (15)

Country Link
US (1) US8753820B2 (enExample)
EP (1) EP2414837B1 (enExample)
JP (1) JP5643288B2 (enExample)
CN (1) CN102549432B (enExample)
AR (1) AR076041A1 (enExample)
BR (1) BRPI1013184A2 (enExample)
CA (1) CA2753718C (enExample)
CO (1) CO6430490A2 (enExample)
MX (1) MX2011008439A (enExample)
MY (1) MY179250A (enExample)
RU (1) RU2523383C2 (enExample)
SG (1) SG173461A1 (enExample)
TW (1) TWI481870B (enExample)
WO (1) WO2010115034A2 (enExample)
ZA (1) ZA201106056B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR076177A1 (es) * 2009-04-01 2011-05-26 Colgate Palmolive Co MÉTODO PARA IDENTIFICAR UN COMPUESTO uTIL PARA TRATAR UNA ENFERMEDAD O CONDICIoN DE LA CAVIDAD ORAL
US9949671B2 (en) 2013-03-13 2018-04-24 Orthoaccel Technologies, Inc. Diagnostic mouthpieces
WO2018129043A1 (en) * 2017-01-03 2018-07-12 The Trustees Of The University Of Pennsylvania Compositions and methods for predicting risk of preterm birth
EP3631462A1 (en) * 2017-05-24 2020-04-08 Koninklijke Philips N.V. Diagnostics of gingivitis based on salivary il-1beta and hgf
EP3631458A1 (en) * 2017-05-24 2020-04-08 Koninklijke Philips N.V. Diagnostics of periodontitis based on salivary hgf and mmp-8
US12050223B2 (en) 2017-05-24 2024-07-30 Koninklijke Philips N.V. Diagnostics of mild or advanced periodontitis based on salivary IL-1BETA and MMP-9
WO2019084351A1 (en) 2017-10-27 2019-05-02 The Regents Of The University Of California SALIVARY EXTRACELLULAR RNA BIOMARKERS FOR GINGIVITIS
EP3477306A1 (en) * 2017-10-30 2019-05-01 Koninklijke Philips N.V. Classification of periodontitis patients

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3538230A (en) 1966-12-05 1970-11-03 Lever Brothers Ltd Oral compositions containing silica xerogels as cleaning and polishing agents
US4358437A (en) 1978-11-29 1982-11-09 Beecham Group Limited Compositions
US5288480A (en) 1987-01-30 1994-02-22 Colgate-Palmolive Co. Antiplaque antibacterial oral composition
GB9117140D0 (en) 1991-08-08 1991-09-25 Unilever Plc Treatment of periodontitis
DE4226043A1 (de) 1992-08-06 1994-02-10 Haarmann & Reimer Gmbh Mittel mit physiologischem Kühleffekt und für diese Mittel geeignete wirksame Verbindungen
EP0728017A1 (en) 1993-11-10 1996-08-28 Bristol-Myers Squibb Company Treatment of bacterially-induced inflammatory diseases
US5578295A (en) 1995-04-28 1996-11-26 The Procter & Gamble Company Oral care compositions comprising certain substituted diphenyl ethers
DE29724204U1 (de) 1996-06-12 2000-09-21 Cognis Deutschland GmbH, 40589 Düsseldorf Kosmetische und/oder pharmazeutische Zubereitungen
FR2794457B1 (fr) 1999-06-01 2001-08-10 Oreal Derives carbonates de retinol, procede de preparation et utilisations
PT2295968E (pt) 1999-12-03 2013-01-09 Baxter Int Teste de pirogenicidade para utilização com sistemas automatizados de imunoensaio
GB0001704D0 (en) 2000-01-25 2000-03-15 Glaxo Group Ltd Protein
JP2003530130A (ja) 2000-04-14 2003-10-14 メタボロン インコーポレイテッド メタボロミクスを使用した薬物発見、疾患の処置、及び診断のための方法
US7329489B2 (en) 2000-04-14 2008-02-12 Matabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
US6500409B1 (en) 2000-05-10 2002-12-31 Colgate Palmolive Company Synergistic antiplaque/antigingivitis oral composition
DE10059584A1 (de) 2000-11-30 2002-06-06 Beiersdorf Ag Kosmetische oder dermatologische getränkte Tücher
US7005225B2 (en) 2002-11-12 2006-02-28 Samsung Electronics Company Organosol including amphipathic copolymeric binder having crystalline material, and use of the organosol to make dry tones for electrographic applications
WO2004073614A2 (en) 2003-02-14 2004-09-02 Combinatorx, Incorporated Combination therapy for the treatment of immunoinflammatory disorders
GB2401865A (en) 2003-05-22 2004-11-24 Givaudan Sa Antibacterial and antifungal glycerol monocarbonates
JP2007514648A (ja) 2003-10-24 2007-06-07 エーザイ株式会社 Toll−likereceptor2に関連する疾患及び状態を治療するための化合物及び方法
CA2546126A1 (en) 2003-12-03 2005-06-23 Christopher Hug Use of t-cadherin as a target
FI20040572A0 (fi) 2004-04-23 2004-04-23 Ctt Cancer Targeting Tech Oy Matriisi-metalloproteinaasin aktiviteetin inhibiittorit
US20050271601A1 (en) * 2004-06-02 2005-12-08 Nebojsa Milanovich Anti-staining antibacterial dentifrice
WO2006068133A1 (ja) * 2004-12-21 2006-06-29 National University Corporation NARA Institute of Science and Technology Nfat2発現抑制方法
US20060141421A1 (en) 2004-12-28 2006-06-29 Kimberly-Clark Worldwide, Inc. System and method for detecting substances related to oral health
WO2006074450A2 (en) 2005-01-07 2006-07-13 President And Fellows Of Harvard College Methods and compositions for detecting and modulating periodontal disorders and periodontal diseases
JP2009523029A (ja) 2006-01-10 2009-06-18 コルゲート・パーモリブ・カンパニー 炎症の予防または軽減のために、細胞表面受容体を調節する方法
US20080161394A1 (en) 2006-11-23 2008-07-03 Jean-Yves Fouron Cosmetic composition comprising at least one volatile carbonic acid ester
WO2008093072A2 (en) 2007-01-29 2008-08-07 Paul Webb Topical composition against contact dermatitis due to water
EP2207546A1 (en) 2007-10-09 2010-07-21 Humco Holding Group, Inc. Antifungal treatment of nails

Also Published As

Publication number Publication date
CN102549432B (zh) 2015-03-25
JP2012522994A (ja) 2012-09-27
WO2010115034A3 (en) 2010-12-29
EP2414837B1 (en) 2015-06-03
TW201102653A (en) 2011-01-16
MY179250A (en) 2020-11-02
ZA201106056B (en) 2015-05-27
RU2011144032A (ru) 2013-05-10
CA2753718A1 (en) 2010-10-07
CN102549432A (zh) 2012-07-04
US20120028261A1 (en) 2012-02-02
AR076041A1 (es) 2011-05-11
RU2523383C2 (ru) 2014-07-20
WO2010115034A2 (en) 2010-10-07
US8753820B2 (en) 2014-06-17
AU2010232593A1 (en) 2011-08-25
TWI481870B (zh) 2015-04-21
CA2753718C (en) 2015-06-23
EP2414837A2 (en) 2012-02-08
BRPI1013184A2 (pt) 2016-04-12
JP5643288B2 (ja) 2014-12-17
SG173461A1 (en) 2011-09-29
MX2011008439A (es) 2011-09-06

Similar Documents

Publication Publication Date Title
AR076041A1 (es) Biomarcadores de proteina para el diagnostico de enfermedades de tejido blando y como objetivos terapeuticos para intervenciones de cuidado oral
DE602006011896D1 (de) Diagnoseverfahren für erkrankungen im zusammenhang mit hirnschäden
MX2020001193A (es) Metodos para determinar dipeptidil peptidasa 3 y metodos terapeuticos.
ES2572372T3 (es) Método de diagnóstico de enfermedades neurodegenerativas basado en la medición de los niveles o de la actividad de SIRT1
ES2569663T3 (es) Procedimiento de diagnóstico
UA101167C2 (ru) Фармацевтическая композиция, предназначенная для лечения глазной болезни
BR112014004336A2 (pt) sistema e método para estimar a quantidade de interesse de um sistema de artéria / tecido / veia dinâmico
NO20062118L (no) Inhibitor kontrastmidler
NO20072120L (no) Enzyme Inhibitor Imaging Agents
BR112021015222A2 (pt) Métodos, sistemas e kits para tratamento de doença inflamatória de alvejamento de il18r1
MY196578A (en) Method for Determining Stage of Periodontal Disease
WO2010047938A3 (en) Mmp activation peptide detection in biological samples
NZ729773A (en) Biomarkers for disease progression in melanoma
BR112014009223A8 (pt) método para o diagnóstico da doença de niemann-pick
WO2018038352A3 (ko) 치매진단용 자가항체 바이오마커 및 이를 이용한 치매진단 방법
JP2012522994A5 (enExample)
BR112013003793A2 (pt) método de diagnóstico das doenças neurodegenerativas
DK1756571T3 (da) Fremgangsmåde i realtid til detektering af akut inflammatoriske tilstande
EP4426860A4 (en) DIRECT NON-INVASIVE PROTEOMIC PROFILING USING STOOL SAMPLES FOR THE DIAGNOSIS OF GASTROINTESTINAL DISEASES
WO2015022646A3 (en) Genetically encoded fret-based mmp-9 activity biosensor and use thereof
CY1111602T1 (el) ΜΕΘΟΔΟΣ ΓΙΑ ΤΗΝ ΑΝΙΧΝΕΥΣΗ ΤΗΣ ΔΡΑΣΤΙΚΟΤΗΤΑΣ IN VIVO ΤΗΣ ΝΕΥΡΟΤΡΥΨΙΝΗΣ, ΧΡΗΣΗ ΤΗΣ ΜΕΘΟΔΟΥ ΚΑΙ ΧΡΗΣΗ TOY C-ΤΕΡΜΑΤΙΚΟΥ 22-kDa ΘΡΑΥΣΜΑΤΟΣ ΤΗΣ ΑΓΡΙΝΗΣ ΩΣ ΒΙΟΔΕΙΚΤΗ ΕΙΣ ΤΗΝ ΔΙΑΓΝΩΣΗ ΚΑΙ ΠΑΡΑΚΟΛΟΥΘΗΣΗ ΔΙΑΤΑΡΑΧΩΝ ΠΟΥ ΕΧΟΥΝ ΣΧΕΣΗ ΜΕ ΝΕΥΡΟΤΡΥΨΙΝΗ
WO2018236134A3 (en) METHOD AND KIT FOR THE DIAGNOSIS OF MUSCLE WEAK RELATED DISEASES USING A BLOOD BIOMARKER
NO20090358L (no) Retinoid-induserbar faktor, og anvendelse derav
EP4183340A4 (en) SAMPLE PAD FOR MEDICAL DIAGNOSTIC KIT AND MANUFACTURING METHOD THEREFOR
EA201500765A1 (ru) Способы лечения сердечно-сосудистых заболеваний

Legal Events

Date Code Title Description
FG Application granted